Development of novel DNA vaccine for VEGF in murine cancer model.
Development of novel DNA vaccine for VEGF in murine cancer model.
复制标题
DOI:
10.1038/srep03380
复制
发表时间:
2013-11-29
影响因子:
4.6
通讯作者:
Morishita, Ryuichi
中科院分区:
文献类型:
--
作者:
Kyutoku, Mariko;Nakagami, Hironori;Koriyama, Hiroshi;Tomioka, Hideki;Nakagami, Futoshi;Shimamura, Munehisa;Kurinami, Hitomi;Zhengda, Pang;Jo, Dong Hyun;Kim, Jeong Hun;Takakura, Nobuyuki;Morishita, Ryuichi
We developed DNA vaccine for vascular endothelial growth factor (VEGF), which may provide the therapeutic option instead of anti-VEGF antibody, bevacizumab. Plasmid containing VEGF mini-gene was constructed in the insertion of B-cell epitope of Hepatitis B core protein [HBc-VEGF], which was an epitope carrier. High titer of anti-VEGF antibody was observed in BALB/c mice which were intramuscularly immunized with HBc-VEGF by electropolator. In mice inoculated with colon 26 cells, tumor volume and microvessel density was decreased in HBc-VEGF with a significant prolonged survival. Co-treatment of purified IgG from immunized mice with HBc-VEGF showed in vitro neutralizing activity for VEGF-induced ERK phosphorylation and tube formation in cultured endothelial cells. Furthermore, intravitreally injection of this purified IgG reduced the neovessel formation in the mouse oxygen-induced retinopathy and laser-induced choroidal neovascularization models. These results first provided that DNA vaccine against VEGF possessed the anti-angiogenic effect, leading to prolonged survival in mouse cancer model.
登录
查看更多内容
影响因子:
15.9
作者:
Gomez-Manzano, Candelaria;Holash, Jocelyn;Yung, W. K. Alfred
通讯作者:
Yung, W. K. Alfred
影响因子:
158.5
作者:
Sandler, Alan;Gray, Robert;Johnson, David H.
通讯作者:
Johnson, David H.
影响因子:
50.3
作者:
Casanovas, O;Hicklin, DJ;Hanahan, D
通讯作者:
Hanahan, D
影响因子:
3.6
作者:
Dong, Jian;Yang, Jun;Li, Miao
通讯作者:
Li, Miao
影响因子:
45.3
作者:
Giantonio, Bruce J.;Catalano, Paul J.;Benson, Al B., III
通讯作者:
Benson, Al B., III